A Combination of a GnRH Antagonist and Agonist for Fertility Preservation in an Adolescent Female Murine Model

Recent studies have suggested that GnRH agonists (GnRHags) protect ovarian function following chemotherapy. Here, we study the effect of a combination of GnRH antagonist (GnRHan) and GnRHag for gonadal protection from gonadotoxic chemotherapy in adolescent female rats. Cycling Sprague Dawley rats we...

Full description

Saved in:
Bibliographic Details
Published in:Reproductive sciences (Thousand Oaks, Calif.) Calif.), 2017-09, Vol.24 (9), p.1280-1283
Main Authors: Knudtson, Jennifer Flora, Tellez Santos, Marlen, Failor, Courtney M., Binkley, Peter A., Venesky, Jacob P., Tekmal, Rajeshwar R., Robinson, Randal D., Schenken, Robert S.
Format: Article
Language:English
Subjects:
Animals
Antineoplastic Agents, Alkylating - administration & dosage
Cyclophosphamide - administration & dosage
Embryology
Female
Fertility Agents, Female - administration & dosage
Fertility Preservation - methods
Gonadotropin-Releasing Hormone - administration & dosage
Gonadotropin-Releasing Hormone - analogs & derivatives
Hormone Antagonists - administration & dosage
Leuprolide - administration & dosage
Medicine & Public Health
Models, Animal
Obstetrics/Perinatology/Midwifery
Original
Original Article
Ovary - drug effects
Rats
Rats, Sprague-Dawley
Reproductive Medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Recent studies have suggested that GnRH agonists (GnRHags) protect ovarian function following chemotherapy. Here, we study the effect of a combination of GnRH antagonist (GnRHan) and GnRHag for gonadal protection from gonadotoxic chemotherapy in adolescent female rats. Cycling Sprague Dawley rats were treated at adolescent age. Thirty female rats were randomized to 5 treatment groups (n = 6/group): (1) placebo, (2) cyclophosphamide (CPA) alone, (3) GnRHan followed by GnRHag with placebo, (4) GnRHan followed by GnRHag with CPA, and (5) GnRHag with CPA. The main outcome measure was live birth rate (LBR), and secondary measures included rat weight, ovarian volume, and follicles. Group 2 had decreased LBR compared to all other groups. Group 4 and 5 had LBR similar to placebo. There was no difference in the ovarian volume. The CPA-alone group had decreased number of antral follicles compared to control. These studies demonstrate that the combination of GnRHan and GnRHag and GnRHag alone preserved fertility in female adolescent rats following gonadotoxic chemotherapy treatment. The addition of a GnRHan to a GnRHag does not confer a greater protective effect.
ISSN:1933-7191
1933-7205
DOI:10.1177/1933719116682876